Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01989169 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01989169 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 30 participants.
The verdict
NCT01989169, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
A Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 and Midazolam in Healthy Adult Subjects
Interventions
- DRUG Midazolam
- DRUG SSP-004184SS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-11-26 |
| Est. Completion | 2014-01-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01989169
The ClinicalTrials.gov registry entry for NCT01989169 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midazolam is the first listed.
NCT01989169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01989169 about?
NCT01989169 is a clinical study titled "Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects". A Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 and Midazolam in Healthy Adult Subjects
What is the current status of trial NCT01989169?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2013-11-26. Estimated completion is 2014-01-06.
What interventions are being tested in trial NCT01989169?
The interventions under investigation include: Midazolam (DRUG), SSP-004184SS (DRUG).
Who is sponsoring clinical trial NCT01989169?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.